Health Condition 1: null- ASA 1/2 patients with concomitant gall stones and CBD stones
Conditions
Interventions
Intervention1: Endoscopic Stone Extraction followed by Laparoscopic Cholecystectomy in group II: Group 2 - Endoscopic Stone Extraction followed by Laparoscopic Cholecystectomy will be compared interms
Sponsors
Society of American Gastrointestinal and Endoscopic SurgeonsSAGES
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with symptomatic gall stone disease with choledocholithiasis 2. Patients with dilated common bile duct.
Exclusion criteria
Exclusion criteria: 1. Patients who do not give consent for participation in the study. 2. Patients with previous hepatobiliary surgery. 3. Patients with morbid obesity. 4. Patients with uncorrectable coagulopathy. 5. Patients unfit for GA. 6. Patients who have undergone previous endoscopic papillotomy / sphincterotomy. 7. Patients with significant comorbid conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success of CBD stone and gall bladder removal by intended modality i.e. by laparoscopic CBD exploration and cholecystectomy in group I and by ERCP and laparoscopic cholecystectomy in group IITimepoint: All patients will be followed up at 1 week, 6 weeks, 3 months and 6 months to one year or if they develop symptoms at any time | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications, Cost of procedures, Overall satisfaction scores, Operative time, Hospital stay, Ease of Cholecystectomy, Follow upTimepoint: All patients will be followed up at 1 week, 6 weeks, 3 months and 6 months to one year or if they develop symptoms at any time | — |
Countries
India
Contacts
Public ContactVirinder Kumar Bansal
All India Institute of Medical Sciences, New Delhi, India
Outcome results
None listed